Nautilus Bio (NAUT) Return on Sales by Net Profit

NAUT (nautilus.bio) - company brandmark

Nautilus Biotechnology (NAUT) is developing an advanced proteome study system for the synthesis of modern pharmaceuticals. The historical sales margin level displayed by the GURU.Markets portal confirms this strategy, with the current level sitting around -13816.80. Business efficiency is based on proprietary chips for low-cost DNA screening and modernized optical systems in laboratories.

nautilus.bio (NAUT) - Net Margin from 07/04/2022 to 11/19/2026

Nautilus Bio (NAUT) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analysis:Nautilus Biotechnology
Flagship merchandise of nautilus.bio

Sales margin determines the share of net profit in every dollar of revenue, measuring the efficiency of converting income into final capital. The current value of -13816.80 reflects the ability of Nautilus Biotechnology (NAUT) to retain profit amidst fierce competition with DNA sequencing behemoths. By analyzing the company's sales margin history, an investor can discern the real cost of implementing proteomic tools in laboratories. A compression of this metric signals a loss of competitive advantage, while the stability of the metric confirms the resilience of the business model.

Analysis of competing companies

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX